STP206 for the Prevention of Necrotizing Enterocolitis (NEC)

PHASE1CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

January 30, 2014

Primary Completion Date

February 28, 2018

Study Completion Date

October 22, 2018

Conditions
Necrotizing Enterocolitis
Interventions
BIOLOGICAL

STP206

Live Biotherapeutic

OTHER

Control

Sterile Water

Trial Locations (13)

26506

West Virginia University, Morgantown

27610

WakeMed Health and Hospitals, Raleigh

29425

Medical University South Carolina, Charleston

30912

Augusta University, Augusta

33323

Sheridan Clinical Research / Plantation General Hospital, Sunrise

38163

University of Tennessee, Memphis

60201

NorthShore University HealthSystem, Evanston

62769

Southern Illinois University School of Medicine, Springfield

67214

Wesley Medical Center, Wichita

75075

The Medical Center of Plano, Plano

06106

Connecticut Children's Medical Center, Hartford

02215

Beth Israel Deaconess Medical Center, Boston

01199

Baystate Medical Center, Springfield

Sponsors
All Listed Sponsors
lead

Leadiant Biosciences, Inc.

INDUSTRY

NCT01954017 - STP206 for the Prevention of Necrotizing Enterocolitis (NEC) | Biotech Hunter | Biotech Hunter